ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
18.10.2024 21:31:19 | Diff. +1,180 | Volumen | Geld22:00:01 | Brief22:00:01 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
97,740EUR | +1,22% | 0 Umsatz: 0.000 |
-Geld Vol: - | -Brief Vol: - | 19,92 Mrd.EUR | - | - |
Aktiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 2.038,6000 | 2.015,4000 | 2.077,4000 | 2.047,7000 | 2.016,5000 | ||||||
Immaterielle Vermögensgegenstände | 8.353,4000 | 7.684,6000 | 7.257,6000 | 7.055,5000 | 6.299,8000 | ||||||
Finanzanlagen | - | - | - | - | - | ||||||
Anlagevermögen | 21.449,2000 | 19.699,4000 | 19.914,8000 | 19.334,4000 | 18.571,4000 | ||||||
Vorräte | 2.081,8000 | 2.256,5000 | 2.385 | 2.450,7000 | 2.394,5000 | ||||||
Forderungen | 1.494,6000 | 1.275,8000 | 1.363,9000 | 1.452,7000 | 1.404,9000 | ||||||
Liquide Mitteln | 524,4000 | 542,8000 | 617,9000 | 802,1000 | 478,5000 | ||||||
Umlaufvermögen | 4.515,3000 | 4.427,4000 | 4.723,9000 | 5.083,3000 | 4.885 | ||||||
Aktiva, gesamt | 25.964,5000 | 24.126,8000 | 24.638,7000 | 24.417,7000 | 23.456,4000 |
Passiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 330,2000 | 362,6000 | 400,9000 | 330 | 351,2000 | ||||||
Langfristige Schulden | 8.917,5000 | 8.413,7000 | 6.721,4000 | 7.626,5000 | 5.463,7000 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
Rückstellungen | 1.101,5000 | 999,5000 | 840,1000 | 790,4000 | 665,6000 | ||||||
Verbindlichkeiten | 14.229 | 12.850,7000 | 12.245,9000 | 12.218,3000 | 10.790 | ||||||
Gezeichnetes Kapital | 3,1000 | 3,1000 | 3,1000 | 3,1000 | 3,1000 | ||||||
Eigenkapital | 11.735,5000 | 11.276,1000 | 12.392,8000 | 12.199,4000 | 12.666,4000 | ||||||
Minderheitenanteile | -,3000 | 4,8000 | 4,7000 | 5,2000 | 5,7000 | ||||||
Passiva, gesamt | 25.964,5000 | 24.126,8000 | 24.638,7000 | 24.417,7000 | 23.456,4000 |
Gewinn- und Verlustrechnung
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 7.824,1000 | 7.932,9000 | 7.982,2000 | 7.024,5000 | 7.836,2000 | ||||||
Abschreibungen (Gesamt) | 603,9000 | 595,9000 | 584,3000 | 597,6000 | 615,7000 | ||||||
Betriebsergebnis | 808,2000 | 33,8000 | 1.137,5000 | -87,8000 | 780,1000 | ||||||
Zinsergebnis | 2,2000 | -289,3000 | -226,9000 | -212 | -208,4000 | ||||||
Ergebnis vor Steuern | 464,6000 | -271,1000 | 905,8000 | -274,4000 | 418,4000 | ||||||
Ertragsteuern | -1.348,8000 | 108,2000 | -225,7000 | -137 | 16,3000 | ||||||
Gewinnanteil Minderheitsgesellschafter | -,4000 | -,1000 | -,1000 | 1,5000 | ,5000 | ||||||
Konzernjahresüberschuss | 1.813,8000 | -379,2000 | 1.131,6000 | -138,9000 | 401,6000 |
Pro Aktie
Cash Flow
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 1.582,3000 | 1.747,4000 | 1.585,8000 | 1.204,5000 | 1.499,2000 | ||||||
Cash Flow aus Investitionstätigkeit | -510,8000 | -416,6000 | -729,3000 | -613,8000 | -503,6000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -1.210,5000 | -1.302,2000 | -779,9000 | -421,8000 | -1.306 | ||||||
Veränderung der liquiden Mittel | -109,7000 | 18,4000 | 75,1000 | 184,2000 | -323,6000 | ||||||
Anzahl der Mitarbeiter | 18.200 | 19.000 | 19.900 | 20.000 | 19.500 |